CK-0802 is under clinical development by Cellenkos and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Gen1E-1124 is under clinical development by GEn1E Lifesciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Patients with acute respiratory distress syndrome faced an accelerated and ... 1,236 pediatric patients (median age, 4 years) with ARDS from two observational cohorts, 1,079 adults (median age ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both acute lung injury (ALI) and acute ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both acute lung injury and acute ...

Human Metapneumovirus (HMPV) is a contagious respiratory virus causing symptoms similar to RSV and the flu, posing ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Sepsis, a severe and often fatal complication of infection, is a leading cause of both ALI and acute respiratory distress ...

Artificial intelligence and machine learning transforming ICU decision-making: Experts: Shardul Nautiyal, Mumbai Saturday, January 4, 2025, 08:00 Hrs [IST] Artificial intelligence ...

Common severe outcomes include acute respiratory distress syndrome (ARDS), blood clots, multisystem inflammatory syndrome (particularly in children), long COVID (persistent symptoms)and organ ...

Healios KK (JP:4593) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...